Gilead Sciences, Inc.
GILD
$138.92
$0.560.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -619.35% | -7.42% | -28.47% | 55.71% | 49.05% |
| Total Depreciation and Amortization | 1.31% | 0.29% | 0.15% | -0.72% | -0.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,346.79% | -48.63% | 59.07% | 251.05% | -75.61% |
| Change in Net Operating Assets | 105.06% | -17.72% | -103.37% | 85.25% | -94.97% |
| Cash from Operations | 40.45% | -23.53% | -19.01% | 396.74% | -52.93% |
| Capital Expenditure | -19.66% | 42.93% | -39.46% | -37.38% | -2.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -10,183.49% | 82.10% | -264.67% | -695.24% | 92.31% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.80% | 295.49% | -803.54% | 94.32% | -5,131.58% |
| Cash from Investing | -684.58% | 196.46% | -329.74% | 79.82% | -409.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.39% | -34,475.00% | 11.11% | 0.00% | 99.49% |
| Issuance of Common Stock | -94.58% | 418.75% | -67.01% | 259.26% | -89.29% |
| Repurchase of Common Stock | 15.27% | -82.17% | 47.13% | 17.46% | 27.81% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.06% | -4.63% | 1.09% | -1.11% | 1.58% |
| Other Financing Activities | -93.89% | -185.71% | 54.01% | -114.06% | 63.64% |
| Cash from Financing | 155.30% | -235.63% | 15.18% | 4.98% | 54.26% |
| Foreign Exchange rate Adjustments | -72.73% | -320.00% | 200.00% | -106.85% | 284.21% |
| Miscellaneous Cash Flow Adjustments | -200.00% | -- | -- | -- | -- |
| Net Change in Cash | -6,946.15% | -72.22% | -89.30% | 178.55% | -34.77% |